High doses (more than 100 mg/L) of purified human AFP were shown to strongly inhibit the growth of human hepatoma HepG2 cells, human lymphoblastoma MT4 cells, lymphoma Jurkat cells and murine fibroblastoma L929 cells in a dose-dependent manner [79]. This evidence concerns the gene AFP and hepatocellular carcinoma.